Status:
COMPLETED
Comparison of the Transcutaneous Tibial Nerve Stimulation and Drug Treatment' Effects in Women With Overactive Bladder
Lead Sponsor:
Ege University
Conditions:
Overactive Bladder
Overactive Bladder Syndrome
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
Overactive bladder (OAB) syndrome is a symptom complex characterized by sudden urgency, frequent urination, nocturia, and urge incontinence without any identifiable organic cause, significantly impact...
Detailed Description
According to the inclusion and exclusion criteria, 34 female patients with OAB were enrolled in the study. The patients were randomly divided into two groups, with 17 individuals in each group. Patien...
Eligibility Criteria
Inclusion
- Female patients with a diagnosis of OAB and unresponsive to first-line treatment,
- Absence of genito-urinary system malformations that may cause pollacullaire,
- Volunteering to participate in the research,
- To be literate in Turkish
Exclusion
- Having a urinary tract infection,
- Having pelvic organ prolapse greater than stage 2,
- To be diagnosed with stress type urinary incontinence,
- Having narrow-angle glaucoma, myasthenia gravis and severe gastro-intestinal diseases,
- Patients undergoing hemodialysis,
- Having severe liver or kidney failure,
- Pregnancy,
- Having a pacemaker
- Presence of epilepsy,
- The presence of built-in metal in the ankle
- Open ankle wound
Key Trial Info
Start Date :
April 18 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 24 2023
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06024005
Start Date
April 18 2023
End Date
May 24 2023
Last Update
September 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ege University, School of Medicine, Department of Obstetrics and Gynecology
Izmir, Turkey (Türkiye), 35100